Editorial Comment to Association of tumor burden with the eligibility of upfront intensification therapy in metastatic castration-sensitive prostate cancer: A multicenter retrospective study.
Masashi KatoPublished in: International journal of urology : official journal of the Japanese Urological Association (2020)